Aberrant peak lactate response in MS

被引:3
作者
Schlueter, Kathrin [1 ,2 ,6 ]
Maier, Josephina [1 ,2 ]
Patra, Stefan [1 ,2 ]
Gold, Stefan M. [4 ,5 ]
Heesen, Christoph [3 ,4 ]
Schulz, Karl-Heinz [1 ,2 ]
机构
[1] Univ Klinikum Hamburg Eppendorf, Univ Kompetenzzentrum Sport & Bewegungsmed Athlet, Hamburg, Germany
[2] Univ Klinikum Hamburg Eppendorf, Inst & Poliklin Med Psychol, Hamburg, Germany
[3] Univ Klinikum Hamburg Eppendorf, Klin & Poliklin Neurol, Hamburg, Germany
[4] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Inst Neuroimmunol & Multiple Sklerose INIMS, Hamburg, Germany
[5] Charite, Klin Psychiat & Psychotherapie, Campus Benjamin Franklin, Berlin, Germany
[6] Univ Klinikum Heidelberg, NCT, Abt Med Onkol, Heidelberg, Germany
关键词
Exercise; multiple sclerosis; peak blood lactate; maximal workload; QUALITY-OF-LIFE; MULTIPLE-SCLEROSIS; CARDIORESPIRATORY FITNESS; EXERCISE CAPACITY; PHYSICAL-ACTIVITY; DISABILITY; FATIGUE; MEN; ACCUMULATION; IMPAIRMENT;
D O I
10.3233/NRE-172182
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: The peak blood lactate response to an exhaustive exercise test in a number of chronic conditions has been shown to differ from that seen in healthy, untrained individuals. However, this has not been investigated for patients with multiple sclerosis (MS). OBJECTIVE: The main objective was to determine and compare the peak blood lactate response to exercise and the maximal workload between two groups of MS patients with different illness severity. METHODS: Twenty-five patients with a relapsing-remitting disease course (Group RR) and 41 patients with a secondary-or primary chronic progressive disease course (group CP) performed an exhaustive incremental bicycle ergometry. Peak blood lactate, maximal workload, peak oxygen consumption and maximal heart rate were measured. RESULTS: The peak blood lactate levels and maximal workload differed significantly between the groups (group CP < group RR; p < 0.001). Furthermore spiroergometric peak performance markers in both groups were significantly lower than predicted for healthy age and sex matched untrained groups. CONCLUSION: A reduced peak blood lactate response to exercise is a novel finding for MS patients. This calls into doubt if the lactate performance tests and lactate thresholds used for healthy individuals can be transferred to MS patients.
引用
收藏
页码:811 / 822
页数:12
相关论文
共 43 条
[1]   Post-exercise heart rate recovery in healthy, obeses, and COPD subjects: relationships with blood lactic acid and PaO2 levels [J].
Ba, Abdoulaye ;
Delliaux, Stephane ;
Bregeon, Fabienne ;
Levy, Samuel ;
Jammes, Yves .
CLINICAL RESEARCH IN CARDIOLOGY, 2009, 98 (01) :52-58
[2]  
Banzer W, 2012, DEUT Z SPORTMED, V63, P20
[3]   Maximal blood lactate level acts as a major discriminant variable in exercise testing for coronary artery disease detection in men [J].
Barthelemy, JC ;
Roche, F ;
Gaspoz, JM ;
Geyssant, A ;
Minini, P ;
Antoniadis, A ;
Page, E ;
Wolf, JE ;
Wilner, C ;
Isaaz, K ;
Cavallaro, C ;
Lacour, JR .
CIRCULATION, 1996, 93 (02) :246-252
[4]   Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial [J].
Briken, S. ;
Gold, S. M. ;
Patra, S. ;
Vettorazzi, E. ;
Harbs, D. ;
Tallner, A. ;
Ketels, G. ;
Schulz, K. H. ;
Heesen, C. .
MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (03) :382-390
[5]   Multiple sclerosis and physical exercise: recommendations for the application of resistance-, endurance- and combined training [J].
Dalgas, U. ;
Stenager, E. ;
Ingemann-Hansen, T. .
MULTIPLE SCLEROSIS JOURNAL, 2008, 14 (01) :35-53
[6]  
Durstine J.L., 2009, ACSM's exercise management for person with chronic diseases and disabilities
[7]  
Fezer M., 2004, THESIS
[8]   DETERMINATION OF ENDURANCE CAPACITY AND PREDICTION OF EXERCISE INTENSITIES FOR TRAINING AND COMPETITION IN MARATHON RUNNERS [J].
FOHRENBACH, R ;
MADER, A ;
HOLLMANN, W .
INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 1987, 8 (01) :11-18
[9]   Cross-bridge mechanisms of muscle weakness in multiple sclerosis [J].
Garner, DJP ;
Widrick, JJ .
MUSCLE & NERVE, 2003, 27 (04) :456-464
[10]  
Goodwin Matthew L, 2007, J Diabetes Sci Technol, V1, P558